Tissue plasminogen activator (tPA) is the only supported pharmacological thrombolytic medicine because of its ability to recanalize arteries and improve clinical outcomes (National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995). Here, PLAT is linked to stroke disorder.